News

February 2, 2015February 2, 2015

Enbrel Biosimilar by Samsung Bioepis to be Reviewed by EMA

News

Enbrel (etanercept) biosimilar candidate, SB4, developed by Samsung Bioepis Co., Ltd. for patients with moderate-to-severe rheumatoid arthritis, recently received validation and has been accepted for review by the European Medicines Agency (EMA). ... Read more

January 30, 2015January 30, 2015

Cognitive Impairment is Less Pronounced in Rheumatoid Arthritis Compared to Fibromyalgia

News

A paper presented at the last annual meeting of the American College of Rheumatology in November 2014, showed that patients living with a diagnosis of fibromyalgia (FM) exhibited median rates ... Read more

January 28, 2015January 27, 2015

Inhibiting Lipogenesis May Help with Rheumatoid Arthritis Inflammation

News

A new study entitled “Peroxisomal Lipid Synthesis Regulates Inﬂammation by Sustaining Neutrophil Membrane Phospholipid Composition and Viability” published in Cell Metabolism by Irfan J. Lodhi part of Dr. Clay F. ... Read more

January 28, 2015January 28, 2015

Immune Therapeutics Signs With KRS Global Biotech on Low Dose Naltrexone

News

Immune Therapeutics, Inc. has signed an agreement with KRS Global Biotechnology, Inc., to collaborate on compounding, packaging and distributing the drug naltrexone, which is indicated for the treatment of several diseases, including rheumatoid ... Read more

January 27, 2015January 27, 2015

Lung Citrulline Levels Among Smokers May Be Linked to Rheumatoid Arthritis

News

A team of researchers for the University of Oxford found an increase in citrullinated proteins in COPD, suggesting that citrullination in the lungs of smokers is mainly due to inflammation. ... Read more

January 26, 2015January 26, 2015

Arachidonic Acid Intake Not Linked to Rheumatoid Arthritis, Study on Animal Models Shows

News

In a new study entitled “Dietary supplementation with arachidonic acid increases arachidonic acid content in paw, but does not affect arthritis severity or prostaglandin E2 content in rat adjuvant-induced arthritis ... Read more

January 23, 2015January 23, 2015

Reducing Abatacept Dose in Early RA Does Not Affect Remission

News, rheumatoid arthritis

A new study on rheumatoid arthritis entitled “Maintenance of remission following 2 years of standard treatment then dose reduction with abatacept in patients with early rheumatoid arthritis and poor prognosis” ... Read more

January 22, 2015January 22, 2015

Rheumatoid Arthritis Treatment and Progression Affected by Socioeconomic Status

News, rheumatoid arthritis

A Canadian study on rheumatoid arthritis (RA) revealed the influence of clinical and socioeconomic variables in the discontinuation of biologic therapy by RA patients. The study entitled “Biologic Discontinuation in ... Read more

January 21, 2015January 22, 2015

Rheumatoid Arthritis Patients Carry Marker for Personalized Therapeutics

News

Mayo Clinic recently presented a study, at the American College of Rheumatology annual meeting in Boston, showing type 1 interferon as an effective marker to discriminate which treatment rheumatoid arthritis patients should ... Read more

January 19, 2015January 20, 2015

Biosimilars to Raise Rheumatoid Arthritis Therapies’ Value Until 2023

News

The market for the treatment of rheumatoid arthritis (RA) will continue to experience a steady growth internationally, from a $15.6 billion value in 2013 to $19.3 billion come 2023, which matches 2.1% ... Read more